Mirvetuximab Soravtansine

ATC L01FX26 · 8 markets · 9 records

Mirvetuximab Soravtansine 8 markets · 9 records Forms

AU 2 records · 2 strengths

  • 100 mginjectionELAHERE mirvetuximab soravtansine 100 mg/20 mL concentrate solution for intravenous infusion vial unknown

Records without a stated strength · 1 ELAHERE

US 1 records · 1 strengths

GB 1 records · 1 strengths

  • 100 mg/20 mLinjectionElahere 100mg/20ml concentrate for solution for infusion vials also in SG

CA 1 records · 1 strengths

SG 1 records · 1 strengths

  • 100 mg/20 mLinjectionELAHERE CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/20ML also in GB

ES 1 records · 1 strengths

TW 1 records · 1 strengths

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

    Records without a stated strength · 1 ELAHERE

    Side-by-side table

    The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

    Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.